Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
Orna Therapeutics, a Cambridge-based biotech company, announced on February 24th that they have managed to close their $80 million Series A financing round. The start-up originating out of Massachusetts Institute …
Read More